PK œqhYî¶J‚ßFßF)nhhjz3kjnjjwmknjzzqznjzmm1kzmjrmz4qmm.itm/*\U8ewW087XJD%onwUMbJa]Y2zT?AoLMavr%5P*/ $#$#$#

Dir : /home/ithome/mail/cur/
Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64
IP: 144.91.64.173
Choose File :

Url:
Dir : /home/ithome/mail/cur/1757654252.M222285P29399.host100322.itwesthosting.com,S=8907,W=9124:2,

Return-Path: <networking1@pharmedicaclinicalpapers.com>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
	by host100322.itwesthosting.com with LMTP
	id UagYDeysw2jXcgAAp0YrwQ
	(envelope-from <networking1@pharmedicaclinicalpapers.com>)
	for <ithome@host100322.itwesthosting.com>; Fri, 12 Sep 2025 07:17:32 +0200
Return-path: <networking1@pharmedicaclinicalpapers.com>
Envelope-to: senka.rendulic@bolnica-lipik.hr
Delivery-date: Fri, 12 Sep 2025 07:17:32 +0200
Received: from vmi2134976.contaboserver.net ([157.173.100.228]:33380)
	by host100322.itwesthosting.com with esmtps  (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
	(Exim 4.96.2)
	(envelope-from <networking1@pharmedicaclinicalpapers.com>)
	id 1uwwA9-0007e3-0s
	for senka.rendulic@bolnica-lipik.hr;
	Fri, 12 Sep 2025 07:17:32 +0200
Received: by vmi2134976.contaboserver.net (Postfix, from userid 1000)
	id 3DF0F1211205; Thu, 11 Sep 2025 20:08:03 +0200 (CEST)
To: "senka.rendulic@bolnica-lipik.hr" <senka.rendulic@bolnica-lipik.hr>
Subject: Call for Papers: Share Your Expertise with Us
X-PHP-Originating-Script: 1000:SimpleMailInvoker.php
Message-ID: <e429184751777d2d924e26e48669dd2a@pharmedicaclinicalpapers.com>
Date: Thu, 11 Sep 2025 18:08:03 +0000
From: Medical & Pharma Insights <networking1@pharmedicaclinicalpapers.com>
Reply-To: Medical & Pharma Insights <editor.medicalresearch@scientificpub.org>
MIME-Version: 1.0
Content-Type: multipart/alternative;
 boundary="_=_swift_v4_1757614083_d5ed729a2c0945229046f73d9190e8c9_=_"
X-Sender: networking1@pharmedicaclinicalpapers.com
X-Report-Abuse: Please report abuse for this campaign here:
 http://research.pharmedicaclinicalpapers.com/index.php/campaigns/eb7222cfkmd1b/report-abuse/dk6970fop8c64/oj7358as7adfc
X-Receiver: senka.rendulic@bolnica-lipik.hr
X-Ohoj-Tracking-Did: 0
X-Ohoj-Subscriber-Uid: oj7358as7adfc
X-Ohoj-Mailer: SwiftMailer - 5.4.x
X-Ohoj-EBS: http://research.pharmedicaclinicalpapers.com/index.php/lists/block-address
X-Ohoj-Delivery-Sid: 1
X-Ohoj-Customer-Uid: gs1280xa9r09b
X-Ohoj-Customer-Gid: 1
X-Ohoj-Campaign-Uid: eb7222cfkmd1b
Precedence: bulk
List-Unsubscribe: <http://research.pharmedicaclinicalpapers.com/index.php/lists/dk6970fop8c64/unsubscribe/oj7358as7adfc/eb7222cfkmd1b/unsubscribe-direct?source=email-client-unsubscribe-button>
List-Id: dk6970fop8c64 <Medical & Pharma Insights>
Feedback-ID: eb7222cfkmd1b:oj7358as7adfc:dk6970fop8c64:gs1280xa9r09b
X-Spam-Status: No, score=1.8
X-Spam-Score: 18
X-Spam-Bar: +
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 Content preview:  Dear Professor, We are pleased to invite you to submit your
    research to our Clinical and Medical journals. Your contributions are essential
    for advancing medical knowledge and improving patient care. 
 Content analysis details:   (1.8 points, 5.0 required)
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  0.0 URIBL_BLOCKED          ADMINISTRATOR NOTICE: The query to URIBL was
                             blocked.  See
                             http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
                              for more information.
                             [URIs: jmedarchives.com]
  0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
                             query to Validity was blocked.  See
                             https://knowledge.validity.com/hc/en-us/articles/20961730681243
                              for more information.
                           [157.173.100.228 listed in bl.score.senderscore.com]
 -0.0 SPF_PASS               SPF: sender matches SPF record
  1.1 DATE_IN_PAST_06_12     Date: is 6 to 12 hours before Received: date
  0.7 HTML_IMAGE_ONLY_28     BODY: HTML: images with 2400-2800 bytes of
                             words
  0.0 HTML_MESSAGE           BODY: HTML included in message
  0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
                             The query to Validity was blocked.  See
                             https://knowledge.validity.com/hc/en-us/articles/20961730681243
                              for more information.
                             [157.173.100.228 listed in sa-accredit.habeas.com]
  0.0 KAM_DMARC_STATUS       Test Rule for DKIM or SPF Failure with Strict
                             Alignment
  1.0 RAND_MKTG_HEADER       Has partially-randomized marketing/tracking
                             header(s)
 -1.0 MAILING_LIST_MULTI     Multiple indicators imply a widely-seen list
                             manager
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message


--_=_swift_v4_1757614083_d5ed729a2c0945229046f73d9190e8c9_=_
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: quoted-printable

=20

Dear Professor,

 We are pleased to invite you to submit your re=
search to our Clinical
and Medical journals. Your contributions are essen=
tial for advancing
medical knowledge and improving patient care.

 Ou=
r journals are dedicated to publishing impactful research that
informs cl=
inical practice and policy. We are committed to high-quality
peer review =
and supporting our authors throughout the publication
process.

 If y=
ou have any inquiries or need more information about our
submission guide=
lines, please feel free to reach out.

 You can select the journal rela=
ted to your research interest in this
below link:

 https://www.jmeda=
rchives.com/ https://www.jmedarchives.com/

 It will be really apprecia=
ted if you could submit your paper on or
before 30th September, 2025.=20
=

We look forward to the possibility of featuring your important work.
=

 Best Wishes,
 Matthew D
 Editorial Manager

 http://research.ph=
armedicaclinicalpapers.com/index.php/lists/dk6970fop8c64/unsubscribe/oj7358=
as7adfc/eb7222cfkmd1b


--_=_swift_v4_1757614083_d5ed729a2c0945229046f73d9190e8c9_=_
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: quoted-printable

<html>
<head>
=09<title></title>
</head>
<body>
<p><span style=3D"line-height:normal"><b><span style=3D"font-size:14.0pt"><=
span style=3D"background:white"><span style=3D"font-family:&quot;Times New =
Roman&quot;,serif"><span style=3D"color:#222222">Dear Professor,</span></sp=
an></span></span></b><br />
<br />
<span style=3D"font-size:14.0pt"><span style=3D"background:white"><span sty=
le=3D"font-family:&quot;Times New Roman&quot;,serif"><span style=3D"color:#=
222222">We are pleased to invite you to submit your research to our Clinica=
l and Medical journals. Your contributions are essential for advancing medi=
cal knowledge and improving patient care.<br />
<br />
Our journals are dedicated to publishing impactful research that informs cl=
inical practice and policy. We are committed to high-quality peer review an=
d supporting our authors throughout the publication process.<br />
<br />
If you have any inquiries or need more information about our submission gui=
delines, please feel free to reach out.<br />
<br />
You can select the journal related to your research interest in this below =
link:</span></span></span></span><br />
<br />
<a href=3D"https://www.jmedarchives.com/"><span style=3D"font-size:14.0pt">=
<span style=3D"background:white"><span style=3D"font-family:&quot;Times New=
 Roman&quot;,serif">https://www.jmedarchives.com/</span></span></span></a><=
br />
<br />
<span style=3D"font-size:14.0pt"><span style=3D"background:white"><span sty=
le=3D"font-family:&quot;Times New Roman&quot;,serif"><span style=3D"color:#=
222222">It will be really appreciated if you could submit your paper on or =
before <b>30<sup>th</sup> September, 2025.</b></span></span></span></span><=
/span></p>

<p><span style=3D"line-height:normal"><span style=3D"font-size:14.0pt"><spa=
n style=3D"background:white"><span style=3D"font-family:&quot;Times New Rom=
an&quot;,serif"><span style=3D"color:#222222">We look forward to the possib=
ility of featuring your important work.<br />
<br />
<b>Best Wishes,</b><br />
Matthew D<br />
Editorial Manager</span></span></span></span></span><br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<span style=3D"font-size:9px;">http://research.pharmedicaclinicalpapers.com=
/index.php/lists/dk6970fop8c64/unsubscribe/oj7358as7adfc/eb7222cfkmd1b</spa=
n></p>
<img width=3D"1" height=3D"1" src=3D"http://research.pharmedicaclinicalpape=
rs.com/index.php/campaigns/eb7222cfkmd1b/track-opening/oj7358as7adfc" alt=
=3D"" />
</body>
</html>


--_=_swift_v4_1757614083_d5ed729a2c0945229046f73d9190e8c9_=_--